UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Population pharmacokinetics of paracetamol across the human age-range from (pre)term neonates, infants, children to adults

Journal of clinical pharmacology, 2014-06, Vol.54 (6), p.619-629

2014

Volltextzugriff (PDF)

Prevalence and Implications of Abnormal Laboratory Results in Patients in the Terminal Phase of Life

Journal of palliative medicine, 2016-08, Vol.19 (8), p.822-829

2016

Volltextzugriff (PDF)

Alternative drug formulations of docetaxel: a review

Anti-cancer drugs, 2007-02, Vol.18 (2), p.95-103

2007

Volltextzugriff (PDF)

Population Pharmacokinetics of Midazolam and Its Metabolites during Venoarterial Extracorporeal Membrane Oxygenation in Neonates

Clinical pharmacokinetics, 2010-06, Vol.49 (6), p.407-419

2010

Volltextzugriff (PDF)

Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

Clinical cancer research, 2011-01, Vol.17 (2), p.353-362

2011

Volltextzugriff (PDF)

Nonlinear Relationship between Mycophenolate Mofetil Dose and Mycophenolic Acid Exposure: Implications for Therapeutic Drug Monitoring

Clinical journal of the American Society of Nephrology, 2011-03, Vol.6 (3), p.656-663

2011

Volltextzugriff (PDF)

Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis

International journal of antimicrobial agents, 2017-02, Vol.49 (2), p.204-211

2017

Volltextzugriff (PDF)

Population Pharmacokinetics of Mycophenolic Acid: A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients

Clinical pharmacokinetics, 2008-01, Vol.47 (12), p.827-838

2008

Volltextzugriff (PDF)

Population pharmacokinetics of mycophenolic acid in renal transplant recipients

Clinical pharmacokinetics, 2005-01, Vol.44 (10), p.1083-1096

2005

Volltextzugriff (PDF)

Clinical evaluation of vancomycin dosage in pediatric oncology patients

The Pediatric infectious disease journal, 2014-07, Vol.33 (7), p.731-733

2014

Volltextzugriff (PDF)

Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel

Cancer biology & therapy, 2006-07, Vol.5 (7), p.833-839

2006

Volltextzugriff (PDF)

Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock—a two-centre randomised clinical trial

Critical care (London, England), 2022-09, Vol.26 (1), p.1-265, Article 265

2022

Volltextzugriff (PDF)

External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients

Antimicrobial agents and chemotherapy, 2019-05, Vol.63 (5)

2019

Volltextzugriff (PDF)

Ketamine Pharmacokinetics: A Systematic Review of the Literature, Meta-analysis, and Population Analysis

Anesthesiology (Philadelphia), 2020-12, Vol.133 (6), p.1192-1213

2020

Volltextzugriff (PDF)

High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation

Nephrology, dialysis, transplantation, 2010-08, Vol.25 (8), p.2757-2763

2010

Volltextzugriff (PDF)

Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab

mAbs, 2020-01, Vol.12 (1), p.1795492

2020

Volltextzugriff (PDF)

Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis

CPT: pharmacometrics and systems pharmacology, 2023-05, Vol.12 (5), p.706-718

2023

Volltextzugriff (PDF)

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

Haematologica (Roma), 2010-07, Vol.95 (7), p.1106-1113

2010

Volltextzugriff (PDF)

Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients

Pharmaceutical research, 2020-09, Vol.37 (9), p.171-171, Article 171

2020

Volltextzugriff (PDF)

Alternative drug formulations of docetaxel: a review

Anti-cancer drugs, 2007-02, Vol.18 (2), p.95-103

2007

Volltextzugriff (PDF)

Irinotecan chemotherapy during valproic acid treatment: Pharmacokinetic interaction and hepatotoxicity

Cancer biology & therapy, 2007-09, Vol.6 (9), p.1368-1374

2007

Volltextzugriff (PDF)

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing : A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients

Journal of the American Society of Nephrology, 2006-03, Vol.17 (3), p.871-880

2006

Volltextzugriff (PDF)

Optimal Sampling Strategies to Assess Inulin Clearance in Children by the Inulin Single-Injection Method

Clinical chemistry (Baltimore, Md.), 2003-07, Vol.49 (7), p.1170-1179

2003

Volltextzugriff (PDF)

Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance‐Associated Protein 2

American journal of transplantation, 2005-05, Vol.5 (5), p.987-994

2005

Volltextzugriff (PDF)

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients

Haematologica (Roma), 2017-03, Vol.102 (3), p.552-561

2017

Volltextzugriff (PDF)

1 – 25 von 209

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(164)

Publikationsform

Artikel
(207)
Berichte
(2)

Sprache

Englisch
(209)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Population pharmacokinetics of paracetamol across the human age-range from (pre)term neonates, infants, children to adults

Prevalence and Implications of Abnormal Laboratory Results in Patients in the Terminal Phase of Life

Alternative drug formulations of docetaxel: a review

Population Pharmacokinetics of Midazolam and Its Metabolites during Venoarterial Extracorporeal Membrane Oxygenation in Neonates

Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

Nonlinear Relationship between Mycophenolate Mofetil Dose and Mycophenolic Acid Exposure: Implications for Therapeutic Drug Monitoring

Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis

Population Pharmacokinetics of Mycophenolic Acid: A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients

Population pharmacokinetics of mycophenolic acid in renal transplant recipients

Clinical evaluation of vancomycin dosage in pediatric oncology patients

Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel

Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock—a two-centre randomised clinical trial

External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients

Ketamine Pharmacokinetics: A Systematic Review of the Literature, Meta-analysis, and Population Analysis

High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation

Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab

Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients

Alternative drug formulations of docetaxel: a review

Irinotecan chemotherapy during valproic acid treatment: Pharmacokinetic interaction and hepatotoxicity

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing : A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients

Optimal Sampling Strategies to Assess Inulin Clearance in Children by the Inulin Single-Injection Method

Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance‐Associated Protein 2

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients

Suchergebnisse filtern